Innovative pharmaceutical concept stocks have pulled back, with stocks like Sinopharm falling more than 6%.

Innovative drug concept stocks fell, with Xintai and Guangshengtang dropping more than 6%, Shutaishen, Sanshengguojian and other stocks followed the decline.